Cosmo Pharmaceuticals NV (CMOPF)
99.19
+0.02
(+0.02%)
USD |
OTCM |
May 06, 16:00
Cosmo Pharmaceuticals SG&A Expense (TTM) : 30.19M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Amarin Corp. Plc | 92.35M |
| Jazz Pharmaceuticals Plc | 1.295B |
| Prothena Corp. Plc | 59.39M |
| Iterum Therapeutics Plc | 15.57M |
| GH Research Plc | 21.95M |